α2,3-sialyltransferase st3gal iii modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo

79Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.

Abstract

Background: Cell surface sialylation is emerging as an important feature of cancer cell metastasis. Sialyltransferase expression has been reported to be altered in tumours and may account for the formation of sialylated tumour antigens. We have focused on the influence of alpha-2,3-sialyltransferase ST3Gal III in key steps of the pancreatic tumorigenic process. Methodology/PrincipalFindings:ST3Gal III overexpressing pancreatic adenocarcinoma cell lines Capan-1 and MDAPanc-28 were generated. They showed an increase of the tumour associated antigen sialyl-Lewisx. The transfectants' E-selectin binding capacity was proportional to cell surface sialyl-Lewisx levels. Cellular migration positively correlated with ST3Gal III and sialyl-Lewisx levels. Moreover, intrasplenic injection of the ST3Gal III transfected cells into athymic nude mice showed a decrease in survival and higher metastasis formation when compared to the mock cells. Conclusion:In summary, the overexpression of ST3Gal III in these pancreatic adenocarcinoma cell lines underlines the role of this enzyme and its product in key steps of tumour progression such as adhesion, migration and metastasis formation. © 2010 Pérez-Garay et al.

Cite

CITATION STYLE

APA

Pérez-Garay, M., Arteta, B., Pagés, L., de Llorens, R., de Bolós, C., Vidal-Vanaclocha, F., & Peracaula, R. (2010). α2,3-sialyltransferase st3gal iii modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo. PLoS ONE, 5(9), 1–11. https://doi.org/10.1371/journal.pone.0012524

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free